National Institute of Allergy and Infectious Diseases (NIAID)
The investigators will collect a nasal swab and blood sample from the participant when the participant is enrolled on the study and if the participant develops a RVI in the first year after transplant. The investigators will collect a blood sample 100 days after the participant's transplant.
Age
0–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Less than 18 years at the time of anticipated transplant
Participant meets one of the following criteria:
1. scheduled to receive allogeneic hematopoietic cell transplant within 14 days of enrollment or
2. Scheduled to or received solid organ transplant within 7 days before or after enrollment
Participant is receiving care at the time of enrollment at one of the study participating institutions.
Parent/guardian willing and able to provide informed consent, and if appropriate, child willing and able to provide informed assent.
Donor for HCT recipient enrolled on the VIPER study.
Willing and able to provide informed consent.
You may not be if
None
Is not an HCT donor for a participant enrolled on the VIPER study.
Not available to provide pre-transplant research blood sample.
Clareo Health | Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
